Medifast Third Quarter Revenue Falls 36 Percent as Optavia Coach Count Drops to 19,500

BALTIMORE, Md. -- November 3, 2025

Medifast, the parent of Optavia, reported third-quarter revenue of 89.4 million dollars, down 36.2 percent from 140.2 million dollars a year earlier, as the number of active earning Optavia coaches fell 35 percent to 19,500 from 30,000. Average revenue per active earning coach was 4,585 dollars, compared with 4,672 dollars, as client acquisition remained under pressure from the rapid adoption of GLP-1 medications for weight loss.

The company posted a net loss of 2.3 million dollars, or 0.21 dollars per diluted share, compared with net income of 1.1 million dollars, or 0.10 dollars, a year earlier. Gross margin narrowed to 69.5 percent from 75.4 percent, reflecting lost leverage on fixed costs and a reserve for the reformulation of the Essential product line. Medifast ended the quarter with 173.5 million dollars in cash, cash equivalents and investment securities and no debt.

"We're transforming Medifast from a weight-loss company into a leader in promoting metabolic health," said Chairman and Chief Executive Dan Chard. For the fourth quarter, the company expects revenue of 65 million to 80 million dollars and a diluted loss per share of 0.70 to 1.25 dollars.